Similar Papers

Paper Title
Journal
Date
Author
Abstract C135: Discovery of novel MTA-cooperative PRMT5 inhibitors as targeted therapeutics for MTAP-deleted cancers
Adam Radzimierski ... Aneta Bobowska
Molecular Cancer Therapeutics | VOL. 22
Adam Radzimierski, et. al.Adam Radzimierski ... Aneta Bobowska
01 Dec 2023
Abstract 539: LN18-MRTX1719R cell line, a useful cell model for the discovery of the new PRMT5 inhibitors
Yao Tang ... Feng Hao
Cancer Research | VOL. 84
Yao Tang, et. al.Yao Tang ... Feng Hao
22 Mar 2024
Abstract 1140: A novel MTA non-competitive PRMT5 inhibitor
Rohit Malik ...
Cancer Research | VOL. 81
Rohit Malik, et. al.Rohit Malik ...
01 Jul 2021
Arginine Methyltransferase 5 (PRMT5) Inhibitors with 3-(1H-benzo[d]imidazol- 2-yl)anilines Core Identified by Virtual Screening and Biological Evaluation.
Ying Zhang ... Xinlei Zhang
Current pharmaceutical design | VOL. 29
Ying Zhang, et. al.Ying Zhang ... Xinlei Zhang
01 Feb 2023
View more papers

More From: Frontiers in Chemistry

Paper Title
Journal
Date
Author
Establishment and evaluation of a UPLC-MS/MS method for simultaneous determination of bongkrekic acid and dehydroacetic acid in rice noodles
Lingguo Zhao ... Yong Liu
Frontiers in Chemistry | VOL. -
Lingguo Zhao, et. al.Lingguo Zhao ... Yong Liu
28 Jan 2025
Investigating Raman peak enhancement in carboxyl-rich molecules: insights from Au@Ag core-shell nanoparticles in colloids
Junhao Chen ... Xiaohui Song
Frontiers in Chemistry | VOL. 13
Junhao Chen, et. al.Junhao Chen ... Xiaohui Song
27 Jan 2025
Preparation of p-type Fe2O3 nanoarray and its performance as photocathode for photoelectrochemical water splitting
Xiaoli Fan ... Tao Wang
Frontiers in Chemistry | VOL. 13
Xiaoli Fan, et. al.Xiaoli Fan ... Tao Wang
24 Jan 2025
Anti-cancer activity of synthetic gefitinib-1,2,3-triazole derivatives against Hela cells via induction of apoptosis
Zhihong Hu ... Lan Wang
Frontiers in Chemistry | VOL. 13
Zhihong Hu, et. al.Zhihong Hu ... Lan Wang
24 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.